A comprehensive collection of more than 70 research submissions presented at the 2025 Skin of Color Update (SOCU) conference reveals significant progress in understanding and treating dermatologic conditions that disproportionately affect patients with darker skin tones, while also exposing persistent gaps in clinical research and care equity. The Journal of Drugs in Dermatology published these abstracts as an official supplement, capturing current clinical and translational research that addresses the unique dermatologic needs of diverse patient populations.

Why Does Dermatology Research on Skin of Color Matter?

For decades, dermatology has been dominated by research conducted primarily on lighter skin types. This gap has real consequences: conditions like keloids, melasma, and certain forms of alopecia present differently on darker skin and often require specialized treatment approaches. The SOCU 2025 abstracts represent a deliberate effort to fill this void by bringing together established dermatologic leaders, early career faculty, residents, fellows, and medical students to share original clinical findings and translational insights specific to skin of color .

The research compiled in this supplement addresses eight major clinical areas, each representing conditions that either occur more frequently in patients with skin of color or require unique management considerations. By organizing abstracts into these categories, the supplement makes it easier for clinicians and researchers to find evidence that directly applies to their patient populations and research priorities.

What Eight Areas of Dermatology Are Covered in This Research?

• Alopecia Areata: Research exploring hair loss conditions that affect patients across all skin types but may present with different clinical patterns and treatment responses in skin of color populations.
• Aesthetic Dermatology: Studies on cosmetic procedures, skin rejuvenation, and appearance-related treatments tailored to the needs and safety considerations of darker skin types.
• Acne and Rosacea: Clinical investigations into inflammatory skin conditions that can be underdiagnosed or undertreated in patients with skin of color due to visibility challenges and limited research representation.
• Equity and Diversity in Dermatology: Research examining systemic barriers to care, disparities in diagnosis and treatment, and strategies to improve equitable access to dermatologic services.
• Inflammatory Skin Conditions: Studies on atopic dermatitis, eczema, and psoriasis, which may present differently and require modified treatment approaches in skin of color populations.
• Keloids: Research on abnormal scar formation, a condition that occurs at significantly higher rates in individuals with darker skin and requires specialized surgical and medical management.
• Pediatric Dermatology: Clinical work focused on skin conditions affecting children with skin of color, addressing early diagnosis and prevention strategies.
• Pigmentary Disorders: Investigations into melasma, vitiligo, hyperpigmentation, and photodamage, conditions that are particularly prevalent or visible in darker skin types .

How to Stay Informed About Advances in Skin of Color Dermatology

• Access the SOCU 2025 Supplement: Clinicians, researchers, and trainees can download the full eSupplement from the Journal of Drugs in Dermatology website to explore all 70+ abstracts and identify research relevant to their clinical practice or research interests.
• Follow Dermatology Conferences Focused on Equity: Attend or monitor updates from conferences like SOCU that specifically prioritize research on underrepresented populations in dermatology, ensuring you receive the latest evidence-based findings.
• Review Research by Career Stage: The supplement includes contributions from established leaders, early career faculty, residents, and medical students, offering perspectives ranging from foundational research to cutting-edge clinical applications that can inform your own practice.

The SOCU 2025 Poster Abstract eSupplement represents a significant milestone in dermatologic research. By compiling over 70 submissions in one accessible resource, it provides clinicians and researchers with a comprehensive overview of current evidence and emerging trends in skin of color dermatology. The diversity of contributors, spanning from medical students to established dermatologic leaders, reflects a wide range of experience and perspectives that collectively advance the field .

For patients with skin of color, this research matters because it directly influences the quality of care they receive. When dermatologists have access to evidence-based research specific to their patients' skin types, they can diagnose conditions more accurately, recommend more effective treatments, and avoid the pitfalls of applying one-size-fits-all approaches that may not work for darker skin. The abstracts in this supplement blend original clinical findings with practical implications that can immediately improve patient outcomes.

The emphasis on equity and diversity within the research categories also signals a growing recognition that dermatologic disparities are not inevitable. By studying the barriers to care, examining diagnostic accuracy across skin types, and developing treatment protocols informed by diverse patient populations, the dermatology community is working to ensure that advances in skin health benefit everyone, regardless of skin tone.